Author:
Ge Chun,Cao Bei,Feng Dong,Zhou Fang,Zhang Jingwei,Yang Na,Feng Siqi,Wang Guangji,Aa Jiye
Publisher
Springer Science and Business Media LLC
Reference41 articles.
1. Stewart, S. L., King, J. B., Thompson, T. D., Friedman, C. & Wingo, P. A. Cancer mortality surveillance-United States, 1990–2000. MMWR Surveill Summ. 53, 1–108 (2004).
2. O’Driscoll, L. & Clynes, M. Biomarkers and multiple drug resistance in breast cancer. Curr Cancer Drug Targets. 6, 365–384 (2006).
3. Gewirtz, D. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol. 57, 727–741 (1999).
4. Puglisi, F., Cardoso, F., Lebrun, F. & Piccart, D. M. First-Line Treatment of Metastatic Breast Cancer. Am J Cancer. 5, 99–110 (2006).
5. Furusawa, S. et al. Mechanism of resistance to oxidative stress in doxorubicin resistant cells. Biol Pharm Bull. 24, 474–479 (2001).
Cited by
55 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献